immatics biotechnologies GmbH
Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers

Abstract:

A method of eliciting an immune response in a patient who has a cancer includes administering to said patient a composition containing a population of activated T cells that selectively recognize the cancer cells in the patient that aberrantly express a peptide consisting of the amino acid sequence of GVYDGEEHSV (SEQ ID NO: 303), in which the peptide is in a complex with an MHC molecule.